COBERLY v. AUROBINDO PHARMA, LTD. et al
David Coberly |
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., AUROBINDO PHARMA USA, INC., JOHN DOE, MYLAN LABORATORIES LTD. and MYLAN PHARMACEUTICALS INC. |
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION |
1:2022cv07450 |
December 21, 2022 |
US District Court for the District of New Jersey |
Sharon A King |
Robert B Kugler |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 Diversity-Product Liability |
Plaintiff |
Docket Report
This docket was last retrieved on December 29, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 2 SUMMONS ISSUED as to AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jab) |
Member Case Direct File on 12/21/2022, for MDL 2875 VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION. (jab) |
For all Case Management Orders #click here (jab) |
Magistrate Judge Sharon A. King added. (dmw) |
Filing 1 COMPLAINT against AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA, LTD., JOHN DOE, MYLAN LABORATORIES, LTD., MYLAN PHARMACEUTICALS INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13913437) with JURY DEMAND, filed by David Coberly. (Attachments: #1 Civil Cover Sheet Civil Cover Sheet)(Carlson, Craig) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.